Organization
Meridian Bioscience, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Meridian Bioscience, Inc.
... regulators. Now, law firms are racing to represent other victims: shareholders of Meridian Bioscience, which makes the faulty devices. Based in Newtown, Meridian makes clinical ...
... the class action filed on behalf of investors that purchased Meridian Bioscience, Inc. ("Meridian Bioscience" or the "Company") (NASDAQ: VIVO ) securities between March 25, ...
... action lawsuit has been filed on behalf of investors that purchased Meridian Bioscience, Inc.("Meridian Bioscience" or the "Company") (NASDAQ: VIVO ) securities betweenMarch 25, 2016 ...
... LLC ("KSF"), announces that KSF has commenced an investigation into Meridian Bioscience, Inc. (NasdaqGS: VIVO). On January 25, 2017, the Company revealed negative 1Q2017 financial ...
... the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc. ("Meridian") (NASDAQ:VIVO) securities between March 25, 2016 and July 13, 2017. ...
... Offices of Howard G. Smith continues its investigation on behalf of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO ) investors concerning the Company ...
... rights litigation firm, is investigating whether certain directors and officers of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO) breached their fiduciary duties to the ...
... action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc. (NASDAQ: VIVO) who purchased shares between March 25, 2016 and July 13, ...
... the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc. ("Meridian") (NASDAQ:VIVO) securities between March 25, 2016 and July 13, 2017. ...
... All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) between March 25, 2016 and July 13, 2017. You are ...
... Robbins Arroyo LLP is investigating whether certain officers and directors of Meridian Bioscience, Inc. (NasdaqGS: VIVO) breached their fiduciary duties to shareholders. Meridian, a life ...
... class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc. (NASDAQ:VIVO) who purchased shares between March 25, 2016 and July 13, ...
... the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc. ("Meridian") (NASDAQ:VIVO) securities between March 25, 2016 and July 13, 2017. ...
... Offices of Howard G. Smith announces an investigation on behalf of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO ) investors concerning the Company ...
... and distributer of hemp oil and nicotine e-liquids. "The acquisition of Bradley's Bioscience, a market poised to be a $61.4 billion-dollar industry by 2025 is ...
... law firm on behalf of purchasers of the common stock of Meridian Bioscience, Inc. (NASDAQ: VIVO) between March 25, 2016 and July 13, 2017, inclusive ...
... of Vincent Wong notifies investors of an investigation concerning whether Meridian Bioscience, Inc. ("Meridian Bioscience") (NASDAQ:VIVO) violated federal securities laws. Click here to learn about ...
... Arroyo LLP announces that a class action complaint was filed against Meridian Bioscience, Inc. (NasdaqGS: VIVO). The complaint is brought on behalf of all purchasers ...
... investors that a class action lawsuit has been filed against Meridian Bioscience, Inc. ("Meridian Bioscience") (NASDAQ: VIVO) securities and certain of its officers, on behalf ...
... GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fourth quarter and full-year fiscal 2017 net revenues ...
... Robbins Arroyo LLP is investigating whether certain officers and directors of Meridian Bioscience, Inc. (NasdaqGS: VIVO) violated federal laws. Meridian, a life science company, develops, ...
... State Building in New York City announces an investigation against Meridian Bioscience, Inc. (NASDAQ: VIVO)("Meridian" or the "Company") for possible violations of federal securities laws. ...
... Levi & Korsinsky announces it has commenced an investigation of Meridian Bioscience, Inc. (NASDAQ:VIVO) concerning possible violations of federal securities laws. The investigation concerns ...
... CINCINNATI, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that the FDA has issued a Warning Letter ...
Want to see the full history on Meridian Bioscience, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial